A review on Mucoadhesive Buccal Patches

Authors

  • Aspee Singh Institute of Pharmacy, Bundelkhand University Jhansi, Uttar Pradesh, India
  • Upendra Kumar Sharma Institute of Pharmacy, Bundelkhand University Jhansi, Uttar Pradesh, India
  • S.K. Prajapati Institute of Pharmacy, Bundelkhand University Jhansi, Uttar Pradesh, India

DOI:

https://doi.org/10.21276/IJRDPL.2278-0238.2017.6(4).2654-2660

Keywords:

Buccal drug delivery, folding endurance, index, in-vitro drug release, Permeation enhancers, swelling, Thiolated polymer

Abstract

The oral cavity is an attractive site for the delivery of drugs. Through this route it is possible to realize mucosal (local effect) and transmucosal (systemic effect) drug administration. In the first case, the aim is to achieve a site-specific release of the drug on the mucosa, whereas the second case involves drug absorption through the mucosal barrier to reach the systemic circulation.Absorption through the buccal mucosa overcomes premature drug degradation due to the enzyme activity and pH of gastro intestinal tract, avoids active drug loss due to presystemic metabolism, acid hydrolysis and therapeutic plasma concentration of the drug can be rapidly achieved. The adhesive properties of such drug delivery platforms can reduce the enzymatic degradation due to the increased intimacy between the delivery vehicle and the absorbing membrane. However, per oral administration of drugs has disadvantages such as hepatic first pass metabolism and enzymatic degradation within the GI tract, that prohibit oral administration of certain classes of drugs especially peptides and proteins. Consequently, other absorptive mucosa is considered as potential sites for drug administration. Transmucosal routes of drug delivery offer distinct advantages over per oral administration for systemic drug delivery.

Downloads

Download data is not yet available.

References

Jain NK. Controlled and Novel Drug Delivery, CBS Publishers and Distributors, New Delhi, 1997,1: 52-81.

Chowdary KPR, Shrinivas L. Mucoadhesive drug delivery: A review of current status Indian drug 2000: 37 (9):400-405

Khanna R, Agrawal SP Ahuja A. Mucoadhesivebuccal drug delivery system: A potential alternative to conventional therapy Indian journal PharmaSci 1998, 60 (1):1-11

American Academy of paediatrics. Clinical Report. Alternate route of drug administration. Advantage and disadvantage (subject Review). Paediatrics, 1992, 100(1):143-152

Tora-ToraGorahowski. Principals of Anatomy and physiology,Geradi.Tora-Tora and sandro Reynolds Gorahowski, published Harpat Collins college publishers, 1992:7:770-774.

Ross and Wilson. Anatomy and physiology in health and illness, Anne Waugh and Allison gorav published by Churchill livingstone Edinburgh, 2001,9:289-293.

Rajesh B. Gandhi and joseph R. Robinson. Oral Cavity as a site for bioadhesive drug delivery. Adv drug Del Rev. 1994, 13:43-74.

DavidHaris and Joseph R. Robinson Buccal drug delivery via the mucous membrane of the oral cavity. Journal Pharm Sci. 1992,81(1):1-9

Pramod Kumar TM, Shivakumar HG Desai KG. Oral Transmucosal drug delivery system. Indian Drugs 2004,41(2):63-67

ChatterjeeCC.Human Physiology Medical Allied Agency Calcutta,1985,10:427-434.

Shhojaei AH. A systemic drug delivery via the buccal mucosal route, Pharmaceutical technology, 2001, 70-81.

Swarbrickjames. Bioadhesive Drug Delivery Systems. Marcel Dekker Inc, New York, 1999,541-562

Katarina Edsman and HelenneHagerstrom Pharmaceutical Application and Mucoadhesion for the non-oral routes.Journal Pharmacy and Pharmacology. 2005,3-19

MadhusudanRao Y Vani G BalaRameshchary R. Design and evaluation of Mucoadhesive drug delivery systems. Indian Drug 1998, 35 (9): 134-141

HannanButcheov. Novel bioadhesive formulation in drug delivery an oral presentation at the British Pharmaceutical conference.The drug delivery company’s pharmaventures Ltd. 2004: 22-26

Baviskar D. et al, development of mucoadhesivebuccal patches containing aceclofenic in vitro evaluation, International journal of pharmatech research coden (USA), 2009(1):978-981

Patel.R et al, development and characterization of mucoadhesivebuccal patches of Solbutamol Sulphate,current drug delivery, 2004 :140 -144

Sevdsenel, Attila A Hincal. Drug permission via buccal route possibilities and limitations.J control release. 2001, 72: 133-211

Suresh B Devid O and james LO. A novel approach to drug delivery. Drug Del Tech 2003,3(3): 12-18

Thimmasetty J, Pandey GS and SatishBabu PR. Design and in vivo evaluation of carvedilolbuccalmucoadhesive patches .Journal pharmascince 2008,21 (3): 241-248.

Published

2017-07-15

How to Cite

Singh, A. ., Sharma, U. K. ., & Prajapati, S. . (2017). A review on Mucoadhesive Buccal Patches. International Journal of Research and Development in Pharmacy & Life Sciences, 6(4), 2654 - 2660. https://doi.org/10.21276/IJRDPL.2278-0238.2017.6(4).2654-2660